Company Information
Company Profile
ExoBiomedical, Inc. is a medical device and biomedical company with a novel and proprietary platform technology (ExoSurge®). The Company is closely held and development has been funded by the founders and from earnings generated at Exo's flagship clinical facility in Atlanta. The company’s first commercial product uses rapid pulses of designed gaseous injections to cause a novel form of drug delivery that notable transforms the efficacy of existing generic drugs into "super drugs" with curative outcomes.
The Company is based in Atlanta, GA, and is actively engaged in bringing its ExoSurge® drug delivery device and drug combination to the market.
The Company believes the technology will offer patients the ability to completely heal their Peyronie's Disease through a series non-invasive treatments with minor discomfort and little downtime.
The Company is based in Atlanta, GA, and is actively engaged in bringing its ExoSurge® drug delivery device and drug combination to the market.
The Company believes the technology will offer patients the ability to completely heal their Peyronie's Disease through a series non-invasive treatments with minor discomfort and little downtime.
We invested over twenty-million dollars developing this breakthrough technology that measurably and permanently removes the plaque and fibrosis associated with Peyronie's Disease.
Our patented device and drug therapies combine a regulated flow of inter-fibrinous pulsated gases with select intralesional drug injections that has been clinically-proven to permanently remove the plaques that cause Peyronie's disease. Our years of research and development understanding the epidemiology of Peyronie's plays a key role in our technology's success.
Our core team is composed of life science veterans, with more than 150 years of life science experience, multiple device clearances, and national company launches.
Latest Presentation
Our newest company presentation will be available soon